港股異動 | 績後獲投行唱好 東嶽集團(0189.HK)大漲超15%再創新高
格隆匯8月31日丨東嶽集團(0189.HK)尾盤漲幅擴大至超15%,年內股價暴漲350%。高見27.3港元再創歷史新高價,大幅成交16億港元,總市值超570億港元 。東嶽集團30日公佈,上半年營業額64.71億元人民幣(下同),按年升39.6%;純利6.03億元,按年升49.3%。瑞信上調其目標價至30港元,評級“跑贏大市”。在今年6月起PVDF(聚偏二氟乙烯,氟碳塗料的原材料之一)價格大幅上漲的背景下,市場憧憬公司主要的盈利增長應該會於今年下半年出現。該行預計公司下半年盈利可比上半年增加107%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.